104 related articles for article (PubMed ID: 29188724)
1. Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology.
Abdel-Rahman O
Future Oncol; 2017 Dec; 13(30):2811-2821. PubMed ID: 29188724
[TBL] [Abstract][Full Text] [Related]
2. Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer.
Abdel-Rahman O
Future Oncol; 2017 Oct; 13(25):2277-2284. PubMed ID: 28976218
[TBL] [Abstract][Full Text] [Related]
3. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system.
Abdel-Rahman O
Clin Transl Oncol; 2018 May; 20(5):670-677. PubMed ID: 29022170
[TBL] [Abstract][Full Text] [Related]
4. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
5. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
Abdel-Rahman O
Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
[TBL] [Abstract][Full Text] [Related]
6. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
8. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database.
Komiya T; Chaaya G; Powell E
Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
Lakha S; Gomez JE; Flores RM; Wisnivesky JP
Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract.
Abdel-Rahman O
Clin Genitourin Cancer; 2018 Aug; 16(4):e859-e865. PubMed ID: 29534942
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
[TBL] [Abstract][Full Text] [Related]
12. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
15. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
16. External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With N3 Disease.
Shin JY; Yoon JK; Marwaha G
Clin Lung Cancer; 2017 Nov; 18(6):e481-e489. PubMed ID: 28559200
[TBL] [Abstract][Full Text] [Related]
17. Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer.
Oweira H; Schmidt J; Mehrabi A; Kulaksiz H; Schneider P; Schöb O; Giryes A; Abdel-Rahman O
Future Oncol; 2018 Jan; 14(1):65-75. PubMed ID: 29235888
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
19. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.
Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN
Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
Shi S; Xie H; Yin W; Zhang Y; Peng X; Yu F; Shemanski KA; Kim AW; Wang X
J Surg Oncol; 2020 Jun; 121(8):1233-1240. PubMed ID: 32170977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
